Time for high-burden countries to lead the tuberculosis research agenda
In a Guest Editorial, Madhukar Pai discusses the need for high-burden burden, middle-income countries to take a leading role in tuberculosis research.
Vyšlo v časopise:
Time for high-burden countries to lead the tuberculosis research agenda. PLoS Med 15(3): e32767. doi:10.1371/journal.pmed.1002544
Kategorie:
Editorial
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pmed.1002544
Souhrn
In a Guest Editorial, Madhukar Pai discusses the need for high-burden burden, middle-income countries to take a leading role in tuberculosis research.
Zdroje
1. World Health Organization. Global Tuberculosis Report 2017. Available from: http://www.who.int/tb/publications/global_report/en/. Accessed 6 March 2018. Geneva: WHO, 2017.
2. G20 Germany 2017. G20 Leaders' Declaration: Shaping an interconnected world. Available from: http://www.g20.utoronto.ca/2017/2017-G20-leaders-declaration.pdf Accessed 6 March 2018. 2017.
3. World Health Organization. Moscow Declaration to End TB. Available from: http://www.who.int/tb/features_archive/Moscow_Declaration_to_End_TB_final_ENGLISH.pdf?ua=1 Accessed 13 Feb 2018. 2017.
4. World Health Organization. UN General Assembly high-level meeting on TB to take place in 2018. Available from: http://www.who.int/tb/features_archive/unga-meeting-tuberculosis/en/. Accessed 13 Feb 2018. 2016.
5. Igoe M. Trump budget proposes more US aid cuts, but backs new DFI. Available from: https://www.devex.com/news/trump-budget-proposes-more-us-aid-cuts-but-backs-new-dfi-92097 Accessed 13 Feb 2018. Devex [Internet]. 2018.
6. Editorial. Toronto Star. It’s time for Canada to do better on foreign aid. Available from: https://www.thestar.com/opinion/editorials/2018/01/15/its-time-for-canada-to-do-better-on-foreign-aid.html Accessed 13 Feb 2018. Toronto: Toronto Star; 2018.
7. Europeal Union. Possible impacts of Brexit on EU development and humanitarian policies. Available from: http://www.europarl.europa.eu/RegData/etudes/STUD/2017/578042/EXPO_STU(2017)578042_EN.pdf Accessed 13 Feb 2018. 2017.
8. Creswell J, Sahu S, Sachdeva KS, Ditiu L, Barreira D, Mariandyshev A, et al. Tuberculosis in BRICS: challenges and opportunities for leadership within the post-2015 agenda. Bulletin of the World Health Organization. 2014;92(6):459–60. doi: 10.2471/BLT.13.133116 24940023; PubMed Central PMCID: PMC4047808.
9. Stop TB Partnership. The Global Plan to End TB 2016–2020. Available from: http://www.stoptb.org/global/plan/default.asp Accessed 21 Feb 2018. Geneva: World Health Organization; 2016. 1–190 p.
10. Tianjin Communique of BRICS Health Ministers Meeting. Available from: http://en.nhfpc.gov.cn/2017-07/17/c_71977.htm Accessed 13 Feb 2018. 2017.
11. World Health Organization. Global Investments in Tuberculosis Research and Development: Past, Present, and Future. URL http://apps.who.int/iris/bitstream/10665/259412/1/9789241513326-eng.pdf?ua=1 Accessed 13 Feb 2018. 2017.
12. Tollefson J. China declared largest source of research articles. Nature 2018;553:390. Available from: https://www.nature.com/articles/d41586-018-00927-4 Accessed 6 March 2018. doi: 10.1038/d41586-018-00927-4 29368724
Štítky
Interné lekárstvoČlánok vyšiel v časopise
PLOS Medicine
2018 Číslo 3
- Statinová intolerance
- Hydroresponzivní krytí v epitelizační fázi hojení rány
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Metamizol v liečbe pooperačnej bolesti u detí do 6 rokov veku
- Co dělat při intoleranci statinů?
Najčítanejšie v tomto čísle
- Forced anal examinations to ascertain sexual orientation and sexual behavior: An abusive and medically unsound practice
- Polycystic ovary syndrome, androgen excess, and the risk of nonalcoholic fatty liver disease in women: A longitudinal study based on a United Kingdom primary care database
- The current and potential health benefits of the National Health Service Health Check cardiovascular disease prevention programme in England: A microsimulation study
- Cardiovascular disease and multimorbidity: A call for interdisciplinary research and personalized cardiovascular care